Erste Asset Management’s Ocular Therapeutix OCUL Stock Holding History

Erste Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.09M	Hold	110,000	–	–	0.01%	445
2026 Q1	$814K	Hold	110,000	–	–	0.01%	463
2025 Q4	$1.35M	Sell	110,000 -125,800	-53%	-$1.53M	0.01%	403
2025 Q3	$2.95M	Hold	235,800	–	–	0.03%	310
2025 Q2	$2.17M	Hold	235,800	–	–	0.02%	387
2025 Q1	$1.79M	Hold	235,800	–	–	0.02%	320
2024 Q4	$1.99M	Hold	235,800	–	–	0.02%	325
2024 Q3	$2.05M	Hold	235,800	–	–	0.02%	319
2024 Q2	$1.59M	Hold	235,800	–	–	0.02%	327
2024 Q1	$2.2M	Hold	235,800	–	–	0.03%	292
2023 Q4	$1.07M	Buy	235,800 +77,000	+48%	+$228K	0.02%	368
2023 Q3	$507K	Hold	158,800	–	–	0.01%	405
2023 Q2	$805K	Hold	158,800	–	–	0.01%	378
2023 Q1	$819K	Hold	158,800	–	–	0.02%	384
2022 Q4	$445K	Buy	158,800 +63,000	+66%	+$209K	0.01%	435
2022 Q3	$491K	Hold	95,800	–	–	0.01%	425
2022 Q2	$373K	Hold	95,800	–	–	0.01%	457
2022 Q1	$484K	Hold	95,800	–	–	0.01%	440
2021 Q4	$632K	Hold	95,800	–	–	0.01%	407
2021 Q3	$971K	Buy	95,800 +26,000	+37%	+$292K	0.02%	341
2021 Q2	$960K	Hold	69,800	–	–	0.02%	346
2021 Q1	$1.12M	Buy	69,800 +17,800	+34%	+$343K	0.03%	326
2020 Q4	$1.04M	Buy	+52,000	New	+$772K	0.03%	331

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Erste Asset Management's OCUL Position: Q2 2026 in Review

Erste Asset Management held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 110,000 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #445.

Erste Asset Management first reported a position in OCUL in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.95M in Q3 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

Erste Asset Management held 110,000 shares of Ocular Therapeutix worth $1.09M as of Q2 2026.
Erste Asset Management left its Ocular Therapeutix share count unchanged in Q2 2026.
Ocular Therapeutix made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #445 holding.
Erste Asset Management first reported a position in Ocular Therapeutix in Q4 2020 and has held it in 23 quarters since.
Erste Asset Management's Ocular Therapeutix position peaked at $2.95M in Q3 2025.
262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.